Quantitative risk monitoring for Medifakt (fakt). Last updated 2026-03-12.
Is Medifakt safe? ZARQ monitors Medifakt (fakt) with a risk score based on Distance-to-Default of 2.4 and crash probability of 33%. Alert level: WARNING. Risk grade: B-. Vitality Score: 40/100 (Grade D), indicating crash resistance — backtested high-Vitality tokens lost 44% less during the 2025-2026 market crash (p < 0.001). Investors searching for Medifakt safety information should note this token is monitored daily via ZARQ's quantitative risk engine. Full credit rating pending.
Vitality Score Breakdown
The ZARQ Vitality Score measures ecosystem health and crash resistance across 5 dimensions. Medifakt scores 40/100 (Grade D), indicating crash resistance — backtested high-Vitality tokens lost 44% less during the 2025–2026 market crash (p < 0.001). Backtested ✓ Methodology
Ecosystem Gravity—
Multi-chain presence, protocol count, DeFi depth
Capital Commitment50
TVL stability, locked capital, market cap rank
Coordination Efficiency40
Audit coverage, category diversity, yield density
Stress Resilience—
Drawdown recovery, NDD stability, crash probability
Organic Momentum50
Rating trend, NDD trend, volume momentum
Data confidence: 60%
Strengths
✓Healthy distance from default (NDD: 2.4)
✓No structural collapse signals detected
Risks
✗Elevated crash probability (33%)
✗Active risk alert: WARNING
✗Full Moody's-style credit rating pending
Medifakt has an elevated crash probability of 33%, warranting extra caution. No structural weaknesses have been detected. The Distance-to-Default stands at 2.4, with an alert level of WARNING. Rating: Pending. Vitality Score: 40/100 (Grade D).
Backtest resultsDisclaimer: This is quantitative risk analysis, not investment advice. Crypto assets are volatile and can lose value rapidly. Never invest more than you can afford to lose. ZARQ provides independent risk data — always do your own research before making investment decisions.
Frequently Asked Questions
Is Medifakt safe to invest in?
Medifakt (fakt) is monitored by ZARQ's risk engine. The current crash probability is 33% and the Distance-to-Default stands at 2.4. The alert level is WARNING, meaning moderate — some structural pressure. A full Moody's-style rating is pending. Always do your own research.
What is Medifakt's risk rating?
Medifakt does not yet have a full credit rating. Its risk grade is B-, calculated from Distance-to-Default (2.4), crash probability (33%), and alert level (WARNING). Higher NDD values indicate greater distance from distress.
Will Medifakt crash?
ZARQ's model estimates a 33% crash probability for Medifakt. The NDD of 2.4 indicates moderate — some structural pressure. These are quantitative estimates updated daily, not investment advice.
Should I invest in Medifakt?
Medifakt is currently monitored by ZARQ with risk grade B-. The crash probability is 33% and the Distance-to-Default is 2.4. These metrics suggest notable downside risk. However, ZARQ provides risk data, not investment advice. All crypto investments carry significant risk, including total loss of capital. Consider your risk tolerance, portfolio diversification, and investment horizon. Never invest more than you can afford to lose.
Medifakt price prediction — what does the risk data say?
ZARQ does not make price predictions for Medifakt. Instead, we provide quantitative risk metrics: the crash probability is 33% (probability of a >50% drawdown), the Distance-to-Default is 2.4, and the alert level is WARNING. No structural weakness signals are active. These risk signals are updated daily and can help inform — but not replace — your own analysis.
Is Medifakt a scam?
ZARQ's analysis of Medifakt shows a risk level of WARNING. No structural collapse signals detected. ZARQ monitors Medifakt daily across 7 quantitative risk signals including Distance-to-Default, crash probability, and structural integrity. While these signals can flag elevated risk, they cannot definitively determine if an asset is fraudulent. Always verify the project's team, code, and community independently.
What are the pros and cons of Medifakt?
Based on ZARQ's quantitative analysis, Medifakt (fakt) has the following strengths: Healthy distance from default (NDD: 2.4); No structural collapse signals detected. Key risks include: Elevated crash probability (33%); Active risk alert: WARNING; Full Moody's-style credit rating pending. These assessments are based on daily-updated risk models and should be considered alongside your own research and risk tolerance.